Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Levetiracetam for Cognition in Schizophrenia
NCT03034356Phase 2Completed
- Sponsor
- VA Office of Research & Development
- Start
- Aug 2018
- Primary completion
- Jun 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of levetiracetam in schizophrenia, schizoaffective disorder, sponsored by VA Office of Research & Development. Started Aug 2018; status: completed.
02
Drugs
levetiracetam
03
Conditions
schizophreniaschizoaffective disorder
Beyond the preview
Go deeper on NCT03034356.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03034356.